Professor James Galloway
Professor of Rheumatology
Biography
James Galloway is an academic rheumatologist. He has research interests in big data, epidemiology and health outcomes, clinical trial design and conduct. He is an honorary consultant rheumatologist based at King’s College Hospital. Clinically he works on inflammatory arthritis, but also has a clinical interest in sarcoidosis and rare rheumatic diseases and diagnostic challenges.
Teaching
- MBBS Chair of Assessment Board Programme Director
- PG Cert in Applied Research Methods Faculty Tutor
- KHP Research Design Course
Research
King’s Health Programmes Attainment Gaps Research Group
Providing culturally appropriate care for all is core to health equality and patient-centred care.
News
Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...
One in five patients with rheumatoid arthritis were undiagnosed during the pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.
Research
King’s Health Programmes Attainment Gaps Research Group
Providing culturally appropriate care for all is core to health equality and patient-centred care.
News
Just one in three people with gout prescribed preventative medication
Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.
Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions
People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...
One in five patients with rheumatoid arthritis were undiagnosed during the pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.